DOCSLIB.ORG

The Elusive Nature and Function of Mesenchymal Stem Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Elusive Nature and Function of Mesenchymal Stem Cells PERSPECTIVES research12 (BOX 2). Nevertheless, many OPINION important aspects regarding MSC biology are still unclear. In this Opinion article, we The elusive nature and function of discuss the well­established properties of MSCs cultured in vitro, and focus on how these properties relate to recent studies that mesenchymal stem cells are beginning to uncover MSC localization and function in vivo. César Nombela-Arrieta, Jerome Ritz and Leslie E. Silberstein Studying MSCs in vitro Abstract | Mesenchymal stem cells (MSCs) are a diverse subset of multipotent Defining MSCs. Stem cells are classically precursors present in the stromal fraction of many adult tissues and have drawn defined by their multipotency and self­ intense interest from translational and basic investigators. MSCs have been renewal (BOX 1). Based on these criteria, the operationally defined by their ability to differentiate into osteoblasts, adipocytes central and most disputed issue is the use and chondrocytes after in vitro expansion. Nevertheless, their identity in vivo, of the term MSC. This term was first used heterogeneity, anatomical localization and functional roles in adult tissue to refer to a hypothetical postnatal, multi­ potent and self­renewing precursor derived homeostasis have remained enigmatic and are only just starting to be uncovered. from an original embryonic MSC, the func­ tion of which was to maintain the turnover Stem cells are clonogenic cells that have two colony­forming unit fibroblasts (CFU­Fs)4, in of skeletal tissues in homeostasis or tissue remarkable features, the ability to differenti­ analogy to their haematopoietic counterpart) repair during adulthood. As described for ate into multiple mature cell types (multi­ that could be selected by adherence to plastic HSCs, MSCs would lie at the top of the potency) and the ability to simultaneously surfaces and expanded in vitro. Further stud­ mesenchymal cell hierarchy and progress replenish the stem cell pool (self­renewal), ies substantiated the ability of cultured cells through discrete stages of differentiation that allow them to sustain tissue develop­ derived from single CFU­Fs to proliferate in an orderly manner to give rise to func­ ment and maintenance1 (BOX 1). The surge of while preserving the ability to differentiate tionally and pheno typically mature tissues, stem cell research arose when it became clear to osteoblasts, adipocytes and chondrocytes including bone, smooth muscle, tendons that all blood cell components are derived in vitro5. Multilineage capacity and prolifera­ and cartilage6. from a rare subset of bone marrow (BM)­ tion in vitro were interpreted at the time as This theoretical model provided an residing haematopoietic stem cells (HSCs), indicative of in vivo multi potency and self­ attractive conceptual framework in which which can be isolated and assayed in vitro renewal, the hallmarks of ‘stemness’. Thus, the stromal multipotent precursor cell and in vivo. Currently, HSCs are the para­ the term mesen chymal stem cell (MSC) was described by Friedenstein was rapidly digmatic and best­characterized example coined and gained acceptance to refer to regarded as the prototypical MSC, despite of tissue­specific stem cells. these newly identified precursor cells6,7. Since the fact that such a cell had not been shown Soon after the discovery of HSCs, studies their original description, stromal cells cat­ to strictly fulfil the attributes conveyed in by Friedenstein and colleagues2 reported that egorized as MSCs based on trilineage (osteo­ the term MSC. First, the biological proper­ the BM stroma can generate bone, fat cells, blast, adipo cyte and chondrocyte) potential ties of multipotent progenitors had mostly cartilage and reticular cells following hetero­ in vitro have been isolated from the adherent been inferred from the analysis of clonal topic transplantation (that is, transplantation fraction of many adult and embryonic tissues and non­clonal in vitro­expanded popu­ into a different tissue from that of origin) in in multiple species8–11 (FIG. 1). lations owing to the inability to isolate and mice. This suggested the existence of non­ Multipotentiality in vitro, as well as assay them directly from tissues. Until haematopoietic BM multipotent precursor ease of isolation and expansion, rapidly recently, the multipotency and self­renewal cells with skeletal and adipose potential2,3. positioned MSCs as promising therapeutic of un cultured progenitors had not been fully It was later shown that these precursors were agents in regenerative medicine and made probed using stringent in vitro and in vivo a subset of fibroblast­like cells (defined as them the subject of intensive clinical assays. Furthermore, the existence of a com­ mon postnatal ‘mesenchymal’ progenitor has been questioned, as bone and muscle derive Box 1 | Criteria used to define stem cells: HSCs and BM‑resident MSCs from different progenitors during embryonic Multipotency development, and because whether MSCs The first criterion used to define stem cells is their ability to differentiate into multiple types give rise to muscle cells in vivo has not been of functionally mature specialized cells. Haematopoietic stem cells (HSCs) can give rise to all convincingly demonstrated to date. For this blood cell components, including neutrophils, lymphocytes, natural killer cells, dendritic cells, reason, alter native names such as osteogenic macrophages and monocytes. Bone marrow (BM)-resident mesenchymal stem cells (MSCs) can or skeletal stem cells have been suggested. 1 give rise to osteoblasts, chondrocytes, adipocytes and reticular stroma . Regardless of its inaccuracy13,14, the term Self-renewal MSC has remained prevalent to date to Stem cells also possess the capacity of self-renewal; that is, the ability to undergo numerous cell designate stromal precursors with triline­ divisions while retaining their stem cell identity. HSCs have been shown to self-renew: HSCs age potential isolated from the BM and, by transplanted into irradiated mice can reconstitute the haematopoietic system, including giving extension, from any other mammalian tis­ rise to a population of HSCs that can be serially re-transplanted1. BM-resident MSCs have also sue. Of note, the common use of the name been shown to possess this ability, as their transplantation gives rise to ‘ossicles’ composed of bone, cartilage and reticular stroma, as well as to a population of serially re-transplantable MSCs1. MSC to indistinctively refer to both in vivo precursors and their in vitro­expanded 126 | FEBRUARY 2011 | VOLUME 12 www.nature.com/reviews/molcellbio © 2011 Macmillan Publishers Limited. All rights reserved PERSPECTIVES progeny has frequently led to misconcep­ tions in the field. The International Society for Cellular Therapy, Vancouver, Canada, has recommended the use of the name multipotent mesenchymal stromal cell (also $QPGOCTTQY -KFPG[ 2CPETGCU #FKRQUGVKUUWG 5MGNGVCNOWUENG $TCKP .KXGT abbreviated to MSCs, although not in this Opinion article) for the in vitro cultured cells, restricting the term stem cell to 2GTKXCUEWNCTOWNVKRQVGPV RTGEWTUQTt/5%! des ig nate the proposed in vivo precursors %& or stem cells15,16. 0) 2&)(4β Characterization of mesenchymal stromal cells. Beyond their ability to generate osteo­ blasts, adipocytes and chondrocytes in vitro5, mesenchymal stromal cells give rise to bone %(7( and cartilage after ectopic implantation in vivo17,18 and have been documented to contribute to bone regeneration in animal 19 Multipotent mesenchymal models of genetic bone disorders . Many stromal cell studies have further reported mesenchymal stromal cell differentiation into multiple other cell types of mesodermal and non­ mesodermal origin, including endothelial &GZCOGVJCUQPG +UQDWV[NOGVJ[NZCPVJKPG 6TCPUHQTOKPIITQYVJ cells20, cardiomyocytes21, hepato cytes22 and .CUEQTDKECEKFCPF FGZCOGVJCUQPG HCEVQTβCPFFGZCOGVJCUQPG 23,24 KPQTICPKERJQURJCVG KPFQOGVJCEKPGCPFKPUWNKP neural cells . Nevertheless, such multi­ ! potential capabilities of mesenchymal stro­ mal cells are not universally accepted. There are concerns because of the lack of globally 1UVGQDNCUVU #FKRQE[VGU %JQPFTQE[VGU 1VJGTEGNNV[RGU standardized methods for their isolation, Figure 1 | MSCs and multipotent mesenchymal stromal cells. The plastic-adherent cellular frac- expansion and identification, as well as the tion of many organs contains stromal progenitor cells that 0CVWTcan giveG4G riseXKGYU to ^colonies/QNGEWNCT%GNN$KQNQI[ of fibroblastic range of assays used to define terminally morphology. This cellular subset, known as colony-forming unit fibroblasts (CFU-Fs), totally or partially differentiated, functionally mature popu­ corresponds to a proposed multipotent progenitor cell population, most probably heterogeneous in lations. Claims for in vivo differentiation nature and origin, that resides in the proximity of blood vessels in all tissues studied so far and has been into other cell types are equally controver­ shown to express pericyte-specific markers (CD146, NG2 (also known as CSPG4) and platelet-derived growth factor receptor (PDGFR )). When cultured under the appropriate cell densities, colonies sial, as BM­derived mesenchymal stromal ­β β derived from single CFU-Fs can be isolated and expanded after multiple passages in vitro (indicated cell cultures have been shown to contribute by the curved arrow) without losing their multipotent mesenchymal capacity. These cultured cells, to many tissues following transplantation classically referred to as mesenchymal
Load more

Recommended publications
  • CD34 Negative Hematopoietic Stem Cells
    Sysmex Journal International Vol.12 No.1 (2002) REVIEW ARTICLE CD34 Negative Hematopoietic Stem Cells Fu-sheng WANG R&D, Sysmex Corporation of America, Gilmer Road 6699 RFD, Long Grove, IL 60047-9596, USA. Key Words SERIES 14 CD34– HSC, Biology, Clinical Application Received 2 April, 2002; Accepted 12 April, 2002 INTRODUCTION quent studies3-10), have significantly challenged the exist- ing concepts in stem cell biology and related clinical Two of the most exciting breakthroughs in hematopoietic applications, such as stem cell transplantation and gene stem cell (HSC) research were first, the discovery of therapy4). Therefore, it is not surprising that many HSC CD34 expression on HSC, anti-CD34 antibody develop- investigators have used some interesting titles for their ment and its applications in HSC transplantation1, 2); and papers, and commonly question marks have appeared in secondly, the recent discovery of CD34 negative (CD34–) the article titles. HSC3-10). These discoveries, together with the success in For example: studies of other stem cells, have resulted in the emer- • CD34– stem cells as the earliest precursors of gence of novel clinical treatments in stem cell regenera- hematopoietic progeny5) tive medicine. • Hematopoietic stem cells: Are they CD34-positive or CD34-negative?6) Following the studies of CD34 by Civin1) in 1988, CD34 • CD34+ or CD34–: Does it really Matter? 7) antibody selected cells were successfully used for the • Who is hematopoietic stem cell: CD34+ or CD34–? 8) reconstruction of hematopoiesis in lethally
    [Show full text]
  • Chondrogenesis of Mesenchymal Stem Cells in a Novel Hyaluronate-Collagen-Tricalcium Phosphate Scaffolds for Knee Repair F.G
    EuropeanF Meng et Cells al. and Materials Vol. 31 2016 (pages 79-94) DOI: 10.22203/eCM.v031a06 TCP-COL-HA scaffolds for cartilage ISSN regeneration 1473-2262 CHONDROGENESIS OF MESENCHYMAL STEM CELLS IN A NOVEL HYALURONATE-COLLAGEN-TRICALCIUM PHOSPHATE SCAFFOLDS FOR KNEE REPAIR F.G. Meng§, Z.Q. Zhang§, G.X. Huang, W.S. Chen, Z.J. Zhang, A.S. He and W.M. Liao* Department of Joint Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China §These two authors contributed equally to this work. Abstract Introduction Scaffolds are expected to play a key role in the induction Damaged articular cartilage has poor self-repair capability of chondrogenesis of mesenchymal stem cells (MSCs) owing to the low metabolic rate of chondrocytes (Chen for cartilage tissue regeneration. Here, we report the et al., 2009; Hunziker, 2002; Steadman et al., 2002). development of a novel tricalcium phosphate-collagen- Tissue engineering is considered a potential strategy hyaluronate (TCP-COL-HA) scaffold that can function as for regenerating damaged tissue (Jackson and Simon, a stem cell carrier to induce chondrogenesis and promote 1999). Mesenchymal stem cells (MSCs) are an especially cartilage repair, and the investigation of chondroinductive promising tool since they can be easily isolated from bone properties of scaffolds containing varying amounts of TCP, marrow and expanded in vitro without the loss of their COL and HA. TCP-COL-HA scaffolds, as well as TCP- capacity to differentiate into various cell types, including COL scaffolds at two different TCP/COL ratios (50:50 and chondrocytes and osteoblasts (Caplan, 2005).
    [Show full text]
  • 1. Introduction and Literature Review
    1. Introduction and literature review 1.1 Introduction 1.1.1 Defintion of blood Blood is described as a specialized connective tissue,which circulates in a closed system of blood vessels. (Monica.C, 2009) 1.1.2 Blood components Plasma is 55% of the total blood ,plasma cosist of albumin,globulin,water,electrolyte and many other organic and inorganic substances. (Monica.C, 2009) Blood cells is 45% of total blood and encompass;White blood cells(WBCs),Red blood cells(RBCs),and Platelets(Plts). (Monica.C, 2009) 1.1.3 Function of blood -Respiration: transport of oxygen from the lung to tissues and carbon dioxide from tissues to the lungs. -Excreation:transport of metabolic waste to the lungs,kidneys,skin and intestine for removal. - Maintain of normal acid –base balance. -Nutrition of body . -Part of immune system. (Monica.C, 2009) 1 1.1.4 Haemopoiesis Is the general aspect of blood cells formation. (Monica.C, 2009) Haemopoiesis occurs at different anatomical sites the course of development from embryonic life to adult life this site is, up to 2 month of gestation.The haemopoiesis occurs in yolk sac of the embryo.This period called (Myeloblastic period). (Monica.C, 2009) 2-7 month of gestation, this period called (Haepatic period). (Monica.C, 2009) Only important site of all hemopoiesis site after birth,an exception is lymphocyte production which occur in other organ in addition to the bone marrow.This period called(Myeloid period). (Monica.C, 2009) 1.1.5 Development of haemopoiesis The general most commonly accepted view is that blood cells development from small population of stem cells.
    [Show full text]
  • The Ageing Haematopoietic Stem Cell Compartment
    REVIEWS The ageing haematopoietic stem cell compartment Hartmut Geiger1,2, Gerald de Haan3 and M. Carolina Florian1 Abstract | Stem cell ageing underlies the ageing of tissues, especially those with a high cellular turnover. There is growing evidence that the ageing of the immune system is initiated at the very top of the haematopoietic hierarchy and that the ageing of haematopoietic stem cells (HSCs) directly contributes to changes in the immune system, referred to as immunosenescence. In this Review, we summarize the phenotypes of ageing HSCs and discuss how the cell-intrinsic and cell-extrinsic mechanisms of HSC ageing might promote immunosenescence. Stem cell ageing has long been considered to be irreversible. However, recent findings indicate that several molecular pathways could be targeted to rejuvenate HSCs and thus to reverse some aspects of immunosenescence. HSC niche The current demographic shift towards an ageing popu- The innate immune system is also affected by ageing. A specialized lation is an unprecedented global phenomenon that has Although an increase in the number of myeloid precur- microenvironment that profound implications. Ageing is associated with tissue sors has been described in the bone marrow of elderly interacts with haematopoietic attrition and an increased incidence of many types of can- people, the oxidative burst and the phagocytic capacity of stem cells (HSCs) to regulate cers, including both myeloid and lymphoid leukaemias, and both macrophages and neutrophils are decreased in these their fate. other haematopoietic cell malignancies1,2. Thus, we need individuals12,13. Moreover, the levels of soluble immune to understand the molecular and cellular mechanisms of mediators are altered with ageing.
    [Show full text]
  • Diverse T-Cell Differentiation Potentials of Human Fetal Thymus, Fetal Liver, Cord Blood and Adult Bone Marrow CD34 Cells On
    IMMUNOLOGY ORIGINAL ARTICLE Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cells Ekta Patel,1 Bei Wang,1 Lily Lien,2 Summary Yichen Wang,2 Li-Jun Yang,3 Jan Human haematopoietic progenitor/stem cells (HPCs) differentiate into S. Moreb4 and Lung-Ji Chang1 functional T cells in the thymus through a series of checkpoints. A conve- 1Department of Molecular Genetics and nient in vitro system will greatly facilitate the understanding of T-cell Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA, 2Vectorite development and future engineering of therapeutic T cells. In this report, Biomedica Inc., Taipei, Taiwan, 3Department we established a lentiviral vector-engineered stromal cell line (LSC) of Pathology, Immunology and Laboratory expressing the key lymphopoiesis regulator Notch ligand, Delta-like 1 Medicine, University of Florida, Gainesville, (DL1), as feeder cells (LSC-mDL1) supplemented with Flt3 ligand (fms- 4 FL, USA, and Department of Medicine, like tyrosine kinase 3, Flt3L or FL) and interleukin-7 for the development University of Florida, Gainesville, FL, USA of T cells from CD34+ HPCs. We demonstrated T-cell development from human HPCs with various origins including fetal thymus (FT), fetal liver (FL), cord blood (CB) and adult bone marrow (BM). The CD34+ HPCs from FT, FL and adult BM expanded more than 100-fold before reaching the b-selection and CD4/CD8 double-positive T-cell stage. The CB HPCs, on the other hand, expanded more than 1000-fold before b-selection.
    [Show full text]
  • Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
    International Journal of Molecular Sciences Review Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation Hantae Jo 1,† , Sofia Brito 1,†, Byeong Mun Kwak 2,3,† , Sangkyu Park 4,* , Mi-Gi Lee 5,* and Bum-Ho Bin 1,4,* 1 Department of Applied Biotechnology, Ajou University, Suwon 16499, Korea; [email protected] (H.J.); sofi[email protected] (S.B.) 2 Department of Meridian and Acupoint, College of Korean Medicine, Semyung University, Chungbuk 27136, Korea; [email protected] 3 School of Cosmetic Science and Beauty Biotechnology, Semyung University, 65 Semyung-ro, Jecheon-si, Chungcheongbuk-do 27136, Korea 4 Department of Biological Sciences, Ajou University, Suwon 16499, Korea 5 Bio-Center, Gyeonggido Business and Science Accelerator, Suwon 16229, Korea * Correspondence: [email protected] (S.P.); [email protected] (M.-G.L.); [email protected] (B.-H.B.); Tel.: +82-31-219-2967 (S.P.); +82-31-888-6952 (M.-G.L.); +82-031-219-2816 (B.-H.B.) † These authors contributed equally to this study. Abstract: Mesenchymal stem cells (MSCs) are multipotent stem cells derived from adult stem cells. Primary MSCs can be obtained from diverse sources, including bone marrow, adipose tissue, and umbilical cord blood. Recently, MSCs have been recognized as therapeutic agents for skin regeneration and rejuvenation. The skin can be damaged by wounds, caused by cutting or breaking of the tissue, and burns. Moreover, skin aging is a process that occurs naturally but can be worsened by environmental pollution, exposure to ultraviolet radiation, alcohol consumption, tobacco use, and undernourishment. MSCs have healing capacities that can be applied in damaged and aged Citation: Jo, H.; Brito, S.; Kwak, B.M.; Park, S.; Lee, M.-G.; Bin, B.-H.
    [Show full text]
  • Application Note
    Osteogenic Differentiation and Analysis of MSC Application Note Background Characterization and pancreatic islet cells, has also been observed in vitro when specific culture Mesenchymal stem cells (MSC) are According to the position paper pub- conditions and stimuli are applied [1]. fibroblastoid multipotent adult stem cells lished by the International Society for The directed differentiation of MSC is with a high capacity for self-renewal. So Cellular Therapy (ISCT), MSC express the carried out in vitro using appropriate far, these cells have been isolated from surface markers CD73, CD90 and CD105 differentiation media, such as the ready- several human tissues, including bone and stain negative for CD14 or CD11b, to-use PromoCell MSC Differentiation marrow, adipose tissue, umbilical cord CD34, CD45, CD79α or CD19, and HLA- Media (see below for differentiation matrix, tendon, lung, and the periosteum DR [3]. In addition to surface marker protocol). Terminally differentiated cells [1]. Recently it has been shown that MSC analysis, the most common and reliable are histochemically stained to determine originate from the perivascular niche, a way to identify a population of MSC is their respective identities (see below for tight network present throughout the to verify their multipotency. MSC can staining protocol). vasculature of the whole body. These differentiate into adipocytes, osteoblasts, perivascular cells lack endothelial and he- myocytes, and chondrocytes in vivo matopoietic markers, e.g. CD31, CD34 and in vitro [1,4]. Trans-differentiation
    [Show full text]
  • Visualizing B Cell Development: Creating an Immunology Video Game
    VISUALIZING B CELL DEVELOPMENT: CREATING AN IMMUNOLOGY VIDEO GAME By Emily Lunhui Ling A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Arts Baltimore, Maryland March, 2016 © 2016 Emily L. Ling All Rights Reserved ABSTRACT e foundational immunology concepts of lymphocyte development are important for beginning science students to comprehend. Video games oer the potential for a novel approach to teaching this complex subject matter by more eectively engaging students in this material. However, currently available educational video games intended to teach immunology have distinct limitations such as a lack of explicit demonstrations of the stages of lymphocyte development and clonal selection. is project identies the content focus and gameplay mechanics of currently available immunology video games. Using this as a basis, a novel approach for developing an immunology video game was outlined with the primary goal of improving integration of educational content. A proof of concept was developed for the B lymphocyte development portion of the game content and a partial prototype was developed in Unity 5 3D. e important contribution of this thesis was the development of a new approach to designing a more eective educational video game specically for immunology. Outcomes of this research will serve to inform future biomedical communicators on how to develop content for active learning games in immunology and provide a guide for designing full length educational video games featuring novel gameplay mechanics such as those identied through this project. Emily L. Ling ii CHAIRPERSONS OF THE SUPERVISORY COMMITTEE esis Preceptor Mark J. Soloski, Ph.D., Professor of Medicine Departments of Medicine, Pathology, Molecular Biology and Genetics, and Molecular Microbiology and Immunology Director, Immunology Training Program e Johns Hopkins University School of Medicine Departmental Advisor David A.
    [Show full text]
  • Review Article Mesenchymal Stromal Cells Affect Disease Outcomes Via Macrophage Polarization
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Stem Cells International Volume 2015, Article ID 989473, 11 pages http://dx.doi.org/10.1155/2015/989473 Review Article Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization Guoping Zheng,1 Menghua Ge,1 Guanguan Qiu,1 Qiang Shu,2 and Jianguo Xu1,3 1 Shaoxing Second Hospital, Shaoxing, Zhejiang 312000, China 2The Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China 3The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China Correspondence should be addressed to Jianguo Xu; [email protected] Received 18 May 2015; Accepted 30 June 2015 Academic Editor: Armand Keating Copyright © 2015 Guoping Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Mesenchymal stromal cells (MSCs) are multipotent and self-renewable cells that reside in almost all postnatal tissues. In recent years, many studies have reported the effect of MSCs on the innate and adaptive immune systems. MSCs regulate the proliferation, activation, and effector function of T lymphocytes, professional antigen presenting cells (dendritic cells, macrophages, and B lymphocytes), and NK cells via direct cell-to-cell contact or production of soluble factors including indoleamine 2,3-dioxygenase, prostaglandin E2, tumor necrosis factor- stimulated gene/protein 6, nitric oxide, and IL-10. MSCs are also able to reprogram macrophages from a proinflammatory M1 phenotype toward an anti-inflammatory M2 phenotype capable of regulating immune response.
    [Show full text]
  • Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1
    2912 Vol. 8, 2912–2923, September 2002 Clinical Cancer Research Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1 Jennifer A. Tuxhorn, Gustavo E. Ayala, Conclusions: The stromal microenvironment in human Megan J. Smith, Vincent C. Smith, prostate cancer is altered compared with normal stroma and Truong D. Dang, and David R. Rowley2 exhibits features of a wound repair stroma. Reactive stroma is composed of myofibroblasts and fibroblasts stimulated to Departments of Molecular and Cellular Biology [J. A. T., T. D. D., express extracellular matrix components. Reactive stroma D. R. R.] and Pathology [G. E. A., M. J. S., V. C. S.] Baylor College of Medicine, Houston, Texas 77030 appears to be initiated during PIN and evolve with cancer progression to effectively displace the normal fibromuscular stroma. These studies and others suggest that TGF-␤1isa ABSTRACT candidate regulator of reactive stroma during prostate can- Purpose: Generation of a reactive stroma environment cer progression. occurs in many human cancers and is likely to promote tumorigenesis. However, reactive stroma in human prostate INTRODUCTION cancer has not been defined. We examined stromal cell Activation of the host stromal microenvironment is pre- phenotype and expression of extracellular matrix compo- dicted to be a critical step in adenocarcinoma growth and nents in an effort to define the reactive stroma environ- progression (1–5). Several human cancers have been shown to ment and to determine its ontogeny during prostate cancer induce a stromal reaction or desmoplasia as a component of progression. carcinoma progression. However, the specific mechanisms of Experimental Design: Normal prostate, prostatic intra- stromal cell activation are not known, and the extent to which epithelial neoplasia (PIN), and prostate cancer were exam- stroma regulates the biology of tumorigenesis is not fully un- ined by immunohistochemistry.
    [Show full text]
  • Type 3 Innate Lymphoid Cells a Stromal Cell Niche for Human and Mouse
    A Stromal Cell Niche for Human and Mouse Type 3 Innate Lymphoid Cells Kerim Hoorweg, Priyanka Narang, Zhi Li, Anne Thuery, Natalie Papazian, David R. Withers, Mark C. Coles and Tom This information is current as Cupedo of September 28, 2021. J Immunol 2015; 195:4257-4263; Prepublished online 16 September 2015; doi: 10.4049/jimmunol.1402584 http://www.jimmunol.org/content/195/9/4257 Downloaded from References This article cites 42 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/195/9/4257.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology A Stromal Cell Niche for Human and Mouse Type 3 Innate Lymphoid Cells Kerim Hoorweg,*,1 Priyanka Narang,†,1 Zhi Li,† Anne Thuery,† Natalie Papazian,* David R.
    [Show full text]
  • Tumor Microenvironment Consortium
    Tumor Microenvironment Network (TMEN) Dinah Singer, Ph.D. Director Suresh Mohla, Ph.D. TMEN Program Director Division of Cancer Biology TMEN 2006-2011: Goals – Generate a comprehensive understanding of the composition of the normal stroma and the role of the stroma in tumor initiation, progression and metastasis – Develop resources and infrastructure critical to the broader research community to advance understanding of the tumor microenvironment (TME) TMEN 2006-2011: Current Program •Nine interdisciplinary groups characterizing the TME in major cancer sites, emphasizing human samples •Identifying and translating promising leads •Collaboratively addressing the complexity of TME by assessing: • The co-evolution of tumor-associated stromal cell types and the tumor •Stromal cell interactions with each other and with tumor cells •Generating novel reagents, models and technologies for the research community TMEN 2006-2011: Areas of Emphasis Microenvironment Initiation Progression Metastasis – Tumor initiating cells – Tumor heterogeneity – Stromal cell types and cellular processes – Complex signaling pathways – Genes and genetics TMEN 2006-2011: Scientific Accomplishments Tumor Initiating Cells: • Combined invasive gene signatures in tumor initiating cells and stromal wound repair response genes robustly predict metastasis-free and overall survival in breast, medulloblastoma, lung and prostate cancer patients • New therapeutic approaches to circumvent the chemo- and radio-resistance of tumor initiating cells Stromal Cells: • Delineation of mechanisms
    [Show full text]